Review
Copyright ©The Author(s) 2023.
World J Meta-Anal. Sep 18, 2023; 11(6): 253-265
Published online Sep 18, 2023. doi: 10.13105/wjma.v11.i6.253
Table 2 Molecular target of oxidative stress to promote tumor progression
Molecular target of ROS
Protein or gene
Function and mechanism
Tumor type
ERK1/ERK2ProteinPromotion of cell proliferation and angiogenesisOvarian, colon, breast, and lung cancer
Nrf2ProteinRegulation of oxidative stress by modulating the production of antioxidant enzymesNSCLC and esophageal cancer
Ref1 /APE1ProteinReduction of ROS generationBreast cancer
PTENProteinInvolvement in senescence; Association with high levels of Akt and ROSLung, liver, and breast cancer
RasProteinIncreases mitochondrial mass and ROS levels, causing DNA damage; Regulation of Nox4-p22phox system30% of human cancer
mTORProteinPromotion of cell proliferation and metabolism that contributes to tumor initiation and progression; Regulation of autophagy and apoptosisMore than 70% of cancers (breast, lung, colorectal, prostate, head and neck, gynecologic, urinary bladder, renal cancer gastric carcinoma, glioblastoma, lymphoma, and medulloblastoma)
P38ProteinRegulation of cell proliferation, cell differentiation, cell death, cell migration, and invasion.Prostate, breast, bladder, live, and lung cancer, transformed follicular lymphoma and leukemia
BRCAGeneRegulation of antioxidant response; Controlling the Nrf2 and NFκB activity40%-50% of hereditary breast cancers
hTERTProtein Reduces oxidative stress intracellularly and extracellularly; Regulation of apoptosisGastric cancer, lung cancer, cervical and head cancer, glioblastoma, breast cancer, and ovarian cancer
AngiopoietinProteinInvolvement in angiogenesis, lymphangiogenesis, and metastasis; Induction of hypoxia and cytokinesNSCLC